Christina S. Meade

Christina S. Meade

Associate Professor in Psychiatry and Behavioral Sciences

External Address: 
905 W. Main Street, Suite 24-E, Durham, NC 27701
Internal Office Address: 
905 W. Main Street, Box 102848, Durham, NC 27710
Phone: 
919.613.6549

Overview

Dr. Meade’s domestic research program focuses on predictors of HIV risk behavior in adults with substance use and psychiatric disorders, and the relationship between neuropsychiatric conditions and continued risk behavior in HIV-positive adults. She is particularly interested in how drug addiction and HIV infection impact executive functions, such as decision making, that lead individuals to engage in risky behaviors. Many of her current projects incorporate MRI to isolate the effects of addiction and HIV on both brain function and structure. Dr. Meade is also interested in the development of evidence-based treatments to improve cognitive functioning and reduce risk behaviors among drug users.

Given that most people infected or affected by HIV/AIDS live in Sub-Saharan Africa, Dr. Meade’s international research program is based in South Africa. The Western Cape has experienced a dramatic increase in methamphetamine use since the early 2000s, and there is concern that it may further fuel the HIV epidemic in this country. Current projects focus on characterizing drug addiction and HIV risk behaviors in this understudied group, both in in community and treatment settings, and ultimately increasing uptake of HIV services to improve health outcomes and reduce the continued spread of HIV.

Education & Training

  • Ph.D., Yale University 2006

Selected Grants

Role of cannabis on HIV-related cognitive impairment: a brain connectomics study awarded by National Institutes of Health (Principal Investigator). 2018 to 2023

MRI data fusion to investigate effects of drug abuse on HIV neurological complications awarded by National Institutes of Health (Principal Investigator). 2018 to 2023

Mobile health interventions for varenicline adherence among HIV-positive smokers awarded by National Institutes of Health (Co-Mentor). 2017 to 2022

Mobile health interventions for varenicline adherence among HIV-positive smokers awarded by National Institutes of Health (Co-Mentor). 2017 to 2022

A Systems Biology Approach to HIV-associated Neurocognitive Impairment: Role of Drug Abuse and Neuroinflammation awarded by National Institutes of Health (Co-Principal Investigator). 2016 to 2021

A Systems Biology Approach to HIV-associated Neurocognitive Impairment: Role of Drug Abuse and Neuroinflammation awarded by National Institutes of Health (Co-Principal Investigator). 2016 to 2021

Interdisciplinary Research Training Program in AIDS awarded by National Institutes of Health (Mentor). 2010 to 2020

Interdisciplinary Research Training Program in AIDS awarded by National Institutes of Health (Mentor). 2010 to 2020

Decision Making and HIV Risk: New Approaches to neuroAIDS Research in Drug Users awarded by National Institutes of Health (Principal Investigator). 2015 to 2020

Cognitive Training to Reduce Impulsivity in HIV-infected Cocaine Users awarded by National Institutes of Health (Principal Investigator). 2016 to 2019

Pages

Miles, M. S., et al. “Emotional distress in african american women with hiv.” HIV: Issues with Mental Health and Illness, 2014, pp. 35–50. Scopus, doi:10.4324/9781315785509. Full Text

Patel, Puja, et al. “Problematic alcohol use among fathers in Kenya: Poverty, people, and practices as barriers and facilitators to help acceptance..” Int J Drug Policy, vol. 75, Nov. 2019. Pubmed, doi:10.1016/j.drugpo.2019.10.003. Full Text

Meade, Christina S., et al. “Synergistic effects of marijuana abuse and HIV infection on neural activation during a cognitive interference task..” Addict Biol, vol. 24, no. 6, Nov. 2019, pp. 1235–44. Pubmed, doi:10.1111/adb.12678. Full Text

Skalski, Linda M., et al. “Sexual Orientation, Religious Coping, and Drug Use in a Sample of HIV-Infected African-American Men Living in the Southern USA..” J Relig Health, vol. 58, no. 4, Aug. 2019, pp. 1368–81. Pubmed, doi:10.1007/s10943-019-00791-0. Full Text

Towe, Sheri L., et al. “A Comparison of Motivations for Marijuana Use in HIV-Positive and HIV-Negative Adults..” Aids Behav, vol. 22, no. 9, Sept. 2018, pp. 2807–14. Pubmed, doi:10.1007/s10461-018-2123-4. Full Text

Bell, Ryan P., et al. “Structural connectome differences in HIV infection: brain network segregation associated with nadir CD4 cell count..” J Neurovirol, vol. 24, no. 4, Aug. 2018, pp. 454–63. Pubmed, doi:10.1007/s13365-018-0634-4. Full Text

Khatiwoda, Prasana, et al. “Facilitators and Barriers to Naloxone Kit Use Among Opioid-Dependent Patients Enrolled in Medication Assisted Therapy Clinics in North Carolina..” N C Med J, vol. 79, no. 3, May 2018, pp. 149–55. Pubmed, doi:10.18043/ncm.79.3.149. Full Text

Skalski, Linda M., et al. “Memory Impairment in HIV-Infected Individuals with Early and Late Initiation of Regular Marijuana Use..” Aids Behav, vol. 22, no. 5, May 2018, pp. 1596–605. Pubmed, doi:10.1007/s10461-017-1898-z. Full Text

Meade, Christina S., et al. “Cocaine and HIV are independently associated with neural activation in response to gain and loss valuation during economic risky choice..” Addict Biol, vol. 23, no. 2, Mar. 2018, pp. 796–809. Pubmed, doi:10.1111/adb.12529. Full Text

Meade, Christina S., et al. “Cocaine dependence modulates the effect of HIV infection on brain activation during intertemporal decision making..” Drug Alcohol Depend, vol. 178, Sept. 2017, pp. 443–51. Pubmed, doi:10.1016/j.drugalcdep.2017.05.043. Full Text

Towe, Sheri L., et al. “The Acceptability and Potential Utility of Cognitive Training to Improve Working Memory in Persons Living With HIV: A Preliminary Randomized Trial..” J Assoc Nurses Aids Care, vol. 28, no. 4, July 2017, pp. 633–43. Pubmed, doi:10.1016/j.jana.2017.03.007. Full Text

Pages